Science Creates partners with Pioneer to accelerate science and tech ventures
Science Creates and Pioneer Group announce partnership that will support the next generation of science and technology ventures across the UK and Ireland.
Bringing protein sequencing into the 21st Century
Portal Biotech is on a mission to revolutionise how we study proteins — the molecules that drive nearly every function in the human body.
Science Creates launches third engineering biology accelerator
Applications are open to join the third cohort of our UKRI-funded flagship programme.
Portal Biotech secures $35M Series A, backed by SCVC’s largest investment yet
The SCVC portfolio company is leveraging AI, bioengineering and custom electronics to deliver the ‘holy grail’ of full-protein sequencing — reshaping our understanding of protein biology and accelerating drug development and diagnostics.
Why Deep Tech? And why now?
To ensure the prosperity of our society and our planet, we must make significant advancements in health and sustainability. Deep Tech startups are our most powerful economic engines to drive these innovations.
When food systems fail
What do we do when the status quo just isn't cutting it? We need to think outside the box — and go inside the lab.
Deep Tech pioneers of tomorrow
The importance of education and outreach in diversifying and empowering the future of science entrepreneurship.
We need a healthcare revolution - and we need it now
Our methods of diagnosing disease are fundamentally flawed, and ever-smarter bacteria are triggering a crisis of global warming proportions. What can we do to keep our healthcare system healthy?
The Deep Tech dilemma
How relevant is product-market fit in the new era of Deep Tech startups?
Shaking up the status quo
Why we’re building better batteries, planet-friendly packaging and a greener grid
The building blocks of a community
Giving scientists the physical infrastructure they need to become entrepreneurs and achieve impact in the real world
Concept to Company
Reflecting upon the enormous opportunity of innovation in EngBio, and the growing pressure for the UK to become a global leader in it.